Skip to content

News Hub

The latest breaking stories

Access up-to-date news and information on a wide range of press releases including business, finance, technology, healthcare, entertainment, and more.

NewsMatch Alert

Discover the most important & comprehensive stories delivered directly to you daily.

  • Business Company News
  • 24/10/2026
  • 11:30
Greenworks

Power your Optimus Crew– Greenworks Commercial OPTIMUS(TM) Ecosystem Arrives at Equip Expo 2026

LOUISVILLE, Ky. — Greenworks Commercial showcased the OPTIMUS commercial ecosystem at Equip Exposition 2026 (formerly GIE+EXPO), held October 20–23 at the Kentucky Exposition Center. The ecosystem brings together mowers, handheld tools and the charging equipment that keeps them running. For landscape contractors and the grounds teams that maintain campuses, corporate grounds and public spaces, the show framed a central question for electrification: not whether a single battery-powered tool can replace a gas unit, but whether an entire crew can run electric from the first job of the day to the last. The showcase also featured the debut of the all-new…

  • Information Technology
  • 24/10/2026
  • 03:52
TecDo Technology Co., Limited

TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work

Guangzhou, China, Oct. 24, 2026 (GLOBE NEWSWIRE) -- Tec-Do today hosted Technology Growth Conference 2026 (TGC 2026) in Guangzhou under the theme “AI is Profitable.” Featuring AI pioneer Dr. Kevin Knight and speakers from OpenAI, Google, Alibaba, ByteDance and Tencent, the conference explored how AI can deliver measurable business value.At the event, Tec-Do launched Navos Pro, which the company describes as the industry’s first Pro-Agent. Built around three attributes—Professional, Proactive and Profitable—the product advances Tec-Do’s results-driven approach to AI for Work.From AI Capabilities to Business Results【Dr. Kevin Knight’s Opening Speech】In his opening keynote, “From Language to Action: The Next Leap…

  • Aviation
  • 24/10/2026
  • 03:07
General Atomics Aeronautical Systems, Inc.

GA-ASI Partnering With Spirit Defense For FQ-42 CCA Production

SAN DIEGO, CA / ACCESS Newswire / October 23, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in Uncrewed Aircraft Systems…

  • Contains:
  • Food Beverages
  • 24/10/2026
  • 01:52
Sustainable Pet Food Foundation

Study Finds Lower Rates of Overweight Among Vegan-Fed Cats

LONDON, UK / ACCESS Newswire / October 23, 2026 / A large-scale survey published in Frontiers in Animal Science has found cats fed vegan…

  • Contains:
  • Medical Health Aged Care
  • 24/10/2026
  • 01:22
BeOne Medicines Ltd.

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching…

  • Contains:
  • Technology Innovation
  • 24/10/2026
  • 01:22
Lifezone Metals

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project

NEW YORK–BUSINESS WIRE– Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners,…

  • Contains:
  • Transport Automotive
  • 24/10/2026
  • 01:07
Leggett Dynamics

Leggett Dynamics’s Mid-Class Massage System Wins Gasgoo’s Best Technical Practice Award

SHANGHAI, CHINA / ACCESS Newswire / October 23, 2026 / Leggett Dynamics today announced that its Mid-Class Massage System (MCM) received Gasgoo’s Best Technical…

  • Contains:
  • Medical Health Aged Care
  • 24/10/2026
  • 00:07
Brenus Pharma

Brenus Pharma’s Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics MADRID–BUSINESS WIRE–…

  • Contains:
  • Medical Health Aged Care
  • 23/10/2026
  • 22:37
Takeda Pharmaceutical Company Limited

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study

Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.